解读线粒体-炎症轴:心力衰竭的洞察力和治疗策略
Baile Zuo1, Xiu Fan2, Dawei Xu2
1Molecular Immunology and Immunotherapy Laboratory, School of Medical Technology, Xinxiang Medical University, Xinxiang, Henan, China.
International immunopharmacology
|July 18, 2024
概括
心力衰竭 (HF) 涉及线粒体功能障碍和炎症,影响心脏的能量产生,导致不良结果. 准这种线粒体-炎症轴可能会改善心脏功能和患者的预后.
科学领域:
- 心脏病学 心脏病学
- 线粒体生物学 线粒体生物学
- 炎症研究 炎症研究
背景情况:
- 尽管医学的进步,心力衰竭 (HF) 呈现出全球显著的发病率和死亡率.
- 线粒体功能障碍,影响ATP的产生和增加氧化应激,是HF发病的核心原因.
- 炎症,标志着细胞因子的升高,也推动了HF的进展.
研究的目的:
- 探索复杂的机制,将线粒体功能障碍和心力衰竭中的炎症联系在一起.
- 为了确定线粒体-炎症轴内的共享途径和潜在的治疗点.
主要方法:
- 综合性文献综述,重点关注分子和细胞机制.
- 分析线粒体活性氧物种 (ROS),失调和线粒体DNA (mtDNA) 释放的作用.
- 检查线粒体功能障碍和HF炎症信号之间的相互作用.
主要成果:
- 线粒体功能障碍通过ROS,不平衡和mtDNA释放加剧炎症.
- 这种相互作用有助于心力衰竭的进展.
- 共享的途径为新的治疗干预提供了机会.
结论:
- 线粒体-炎症轴是心力衰竭的一个关键因素.
- 针对这一轴提供了有前途的治疗策略,以改善心脏功能和患者的治疗结果.
- 对这些相互作用的进一步研究可能会导致更有效的HF治疗.
相关概念视频
Heart Failure Drugs: Inotropic Agents
563
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
563
Electron Transport Chain: Complex I and II
12.7K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.7K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
418
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
418
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
The Inner Mitochondrial Membrane
3.3K
The inner mitochondrial membrane is the primary site of ATP synthesis. The inner membrane domain that forms a smooth layer adjacent to the outer membrane is called the inner boundary membrane. This domain contains membrane transporters that drive metabolites in and out of the mitochondria. In contrast, the inner membrane network that invaginates into the matrix space is called the cristae membrane. This domain accounts for principle mitochondrial function as it accommodates the protein...
3.3K
Mitochondrial Membranes
9.7K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
9.7K


